Long-term effects of spironolactone on proteinuria and kidney function in patients with chronic kidney disease.
- S. BianchiR BigazziV. Campese
- 2 December 2006
Medicine
It is shown that spironolactone may reduce proteinuria and retard renal progression in chronic kidney disease patients and the monthly rate of decrease in estimated glomerular filtration rate from baseline was lower in patients treated with spironOLactone than in controls.
"Zero ischemia" partial nephrectomy: novel laparoscopic and robotic technique.
- I. GillM. Eisenberg M. Desai
- 2011
Medicine, Engineering
Antagonists of aldosterone and proteinuria in patients with CKD: an uncontrolled pilot study.
- S. BianchiRoberto BigazziV. Campese
- 1 July 2005
Medicine
This study shows that spironolactone may effectively reduce proteinuria in patients with CKD and concerns remain in regard to the risk for hyperkalemia in patientswith CKD.
Reactive oxygen species stimulate central and peripheral sympathetic nervous system activity.
- V. CampeseS. YeH. ZhongVijay YanamadalaZhongya YeJosephine Chiu
- 1 August 2004
Medicine, Environmental Science
The notion that ROS may raise BP via activation of the SNS through downregulation of nNOS and NO production is supported, in part by mechanisms independent of NO.
The Importance of Understanding the Stages of COVID-19 in Treatment and Trials.
- D. GriffinDenise Brennan-Rieder P. Marik
- 8 February 2021
Medicine
relevant stages of COVID-19 are identified including three periods: pre-exposure; incubation, and detectable viral replication, and five phases: the viral symptom phase, the early inflammatoryphase, the secondary infection phase,The multisystem inflammatory phase, and the tail phase, which should serve as a framework to guide when CO VID-19 therapeutics are likely to provide benefit rather than harm.
Renal afferent denervation prevents the progression of renal disease in the renal ablation model of chronic renal failure in the rat.
- V. CampeseE. KogosovM. Koss
- 1 November 1995
Medicine
Renal afferent impulses, the posterior hypothalamus, and hypertension in rats with chronic renal failure.
- S. YeB. OzgurV. Campese
- 1 March 1997
Biology, Medicine
It is shown that afferent impulses from an injured kidney increase NE secretion from the posterior hypothalamus and raise blood pressure, which appears to be an important integrative structure of the sympathetic regulation of blood pressure.
Prevalence of microalbuminuria in a large population of patients with mild to moderate essential hypertension.
- R BigazziS. BianchiV. CampeseG. Baldari
- 1992
Medicine
No correlation was found between UAE and MAP or creatinine clearance, and long-term prospective studies are needed to extablish whether an increase in UAE may predict future nephrosclerosis in essential hypertension.
Microalbuminuria predicts cardiovascular events and renal insufficiency in patients with essential hypertension
- Roberto BigazziS. BianchiD. BaldariV. Campese
- 1 September 1998
Medicine
It is suggested that hypertensive individuals with microalbuminuria manifest a greater incidence of cardiovascular events and a greater decline in renal function than do patients with normal UAE.
A controlled, prospective study of the effects of atorvastatin on proteinuria and progression of kidney disease.
- S. BianchiRoberto BigazziA. CaiazzaV. Campese
- 1 March 2003
Medicine
It is shown that treatment with atorvastatin in addition to a regimen with ACE inhibitors or ARBs may reduce proteinuria and the rate of progression of kidney disease in patients with chronic kidney disease, proteinuria, and hypercholesterolemia.
...
...